PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹96 Cr | ₹100 Cr | ₹61 Cr | ₹57 Cr | ₹45 Cr |
What is the latest Contingent Liabilities ratio of PIRAMAL PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹96 Cr |
| Mar2025 | ₹100 Cr |
| Mar2024 | ₹61 Cr |
| Mar2023 | ₹57 Cr |
| Mar2022 | ₹45 Cr |
How is Contingent Liabilities of PIRAMAL PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹96 Cr | -4.05 | |
| Mar2025 | ₹100 Cr | 62.40 | |
| Mar2024 | ₹61 Cr | 7.17 | |
| Mar2023 | ₹57 Cr | 27.55 | |
| Mar2022 | ₹45 Cr | - | |
Compare Contingent Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹23,311.1 Cr | 3.9% | 5% | -12.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 3.9% |
5% |
-12.5% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses